[go: up one dir, main page]

SK281903B6 - Monoestery, farmaceutické kompozície s ich obsahom a ich použitie - Google Patents

Monoestery, farmaceutické kompozície s ich obsahom a ich použitie Download PDF

Info

Publication number
SK281903B6
SK281903B6 SK397-94A SK39794A SK281903B6 SK 281903 B6 SK281903 B6 SK 281903B6 SK 39794 A SK39794 A SK 39794A SK 281903 B6 SK281903 B6 SK 281903B6
Authority
SK
Slovakia
Prior art keywords
monoester
ara
acid
nucleoside
oleyl
Prior art date
Application number
SK397-94A
Other languages
English (en)
Slovak (sk)
Other versions
SK39794A3 (en
Inventor
Are Dalen
Finn Myhren
Bernt Borretzen
Kjell Torgeir Stokke
Original Assignee
Norsk Hydro A. S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro A. S. filed Critical Norsk Hydro A. S.
Publication of SK39794A3 publication Critical patent/SK39794A3/sk
Publication of SK281903B6 publication Critical patent/SK281903B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • External Artificial Organs (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SK397-94A 1991-10-07 1992-09-30 Monoestery, farmaceutické kompozície s ich obsahom a ich použitie SK281903B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9121257A GB2260319B (en) 1991-10-07 1991-10-07 Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
PCT/NO1992/000162 WO1993007163A1 (fr) 1991-10-07 1992-09-30 Composes chimiques

Publications (2)

Publication Number Publication Date
SK39794A3 SK39794A3 (en) 1994-10-05
SK281903B6 true SK281903B6 (sk) 2001-09-11

Family

ID=10702531

Family Applications (1)

Application Number Title Priority Date Filing Date
SK397-94A SK281903B6 (sk) 1991-10-07 1992-09-30 Monoestery, farmaceutické kompozície s ich obsahom a ich použitie

Country Status (27)

Country Link
US (1) US6548486B1 (fr)
EP (1) EP0642525B1 (fr)
JP (1) JP2873313B2 (fr)
KR (1) KR100272732B1 (fr)
AT (1) ATE152454T1 (fr)
CA (1) CA2120725C (fr)
CH (1) CH0642525H1 (fr)
CZ (1) CZ288153B6 (fr)
DE (1) DE69219482T2 (fr)
DK (1) DK0642525T3 (fr)
FI (2) FI990270A0 (fr)
GB (1) GB2260319B (fr)
GR (1) GR3024149T3 (fr)
HK (1) HK1007430A1 (fr)
HU (1) HU219400B (fr)
IL (1) IL103351A (fr)
MX (1) MX9205715A (fr)
NO (1) NO300014B1 (fr)
NZ (1) NZ244535A (fr)
PL (1) PL170846B1 (fr)
RU (1) RU2126417C1 (fr)
SG (1) SG47759A1 (fr)
SK (1) SK281903B6 (fr)
TW (1) TW347333B (fr)
UA (1) UA41296C2 (fr)
WO (1) WO1993007163A1 (fr)
ZA (1) ZA927432B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9307043D0 (en) * 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
US5869493A (en) * 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
GB2321455A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Lipophilic derivatives of biologically active compounds
RU2178710C1 (ru) * 2001-02-08 2002-01-27 Кожемякин Леонид Андреевич Индивидуальные вещества, полученные на основе химического взаимодействия дисульфидсодержащих пептидов с производными пуриновых или пиримидиновых оснований, фармацевтические композиции и препараты на их основе, способы их применения для лечения инфекционных заболеваний и профилактики осложнений
RU2328273C2 (ru) * 2001-12-19 2008-07-10 Рисерч Дивелопмент Фаундейшн Липосомальная доставка соединений, основанных на витамине е
GB0201179D0 (en) * 2002-01-18 2002-03-06 Angeletti P Ist Richerche Bio Therapeutic agents
TWI332507B (en) * 2002-11-19 2010-11-01 Hoffmann La Roche Antiviral nucleoside derivatives
US9029345B2 (en) * 2005-03-16 2015-05-12 Case Western Reserve University Selective inhibitors of translesion DNA replication
WO2006101911A1 (fr) 2005-03-16 2006-09-28 Case Western Reserve University Inhibiteurs selectifs de la replication d'adn de translesion
NO324263B1 (no) * 2005-12-08 2007-09-17 Clavis Pharma Asa Kjemiske forbindelser, anvendelse derav ved behandling av kreft, samt farmasoytiske preparater som omfatter slike forbindelser
ATE482690T1 (de) * 2005-12-14 2010-10-15 Hoffmann La Roche Hcv-prodrug-formulierung
US8497292B2 (en) * 2005-12-28 2013-07-30 Translational Therapeutics, Inc. Translational dysfunction based therapeutics
WO2008150438A1 (fr) * 2007-06-01 2008-12-11 Luitpold Pharmaceuticals, Inc. Conjugués pmea-lipides
CA2717788A1 (fr) 2007-07-09 2009-01-15 Eastern Virginia Medical School Derives nucleosidiques substitues ayant des proprietes antivirales et antimicrobiennes
JP2010540556A (ja) * 2007-09-26 2010-12-24 マウント サイナイ スクール オブ メディシン アザシチジン類似体およびその使用
US9988680B2 (en) 2011-09-01 2018-06-05 Case Western Reserve University Non-natural nucleosides as theranostic agents
US9493500B2 (en) 2012-07-19 2016-11-15 Richard Daifuku Fluorinated pyrimidine analogs and methods of use thereof
US9821173B2 (en) 2013-02-08 2017-11-21 Case Western Reserve University Anti-cancer agents and methods of use
RU2561501C1 (ru) * 2014-08-05 2015-08-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ) Антиретровирусные препараты на основе производных азидотимидина
RU2621145C2 (ru) * 2015-11-03 2017-05-31 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежский государственный университет" (ФГБОУ ВПО "ВГУ") Способ получения липосом
EP3762396A1 (fr) * 2018-03-07 2021-01-13 GlaxoSmithKline Intellectual Property (No.2) Limited Composés utiles dans la thérapie du vih

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920630A (en) 1970-09-24 1975-11-18 Upjohn Co 2,2{40 -Anhydro-ara-cytidine compounds and process of preparation
GB1325798A (en) * 1970-09-24 1973-08-08 Upjohn Co Derivatives of 2,2-anhydro-ara-cytidine
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
DE3100478A1 (de) 1981-01-09 1982-08-12 Dr. Thilo & Co GmbH, 8021 Sauerlach 5'ester von pyrimidinnucleosiden mit antiviraler wirksamkeit, verfahren zur herstellung und daraus hergestellte arzneimittel
US4355032B2 (en) 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
NZ201662A (en) 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation
US4816447A (en) 1981-08-26 1989-03-28 Merck & Co., Inc. Anti-viral guanine compounds
US5250535A (en) 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
US4556659A (en) * 1982-08-09 1985-12-03 Syntex (U.S.A.) Inc. Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents
JPH0655755B2 (ja) * 1985-01-23 1994-07-27 富山化学工業株式会社 新規な5−フルオロ−2′−デオキシウリジン−3′−ホスフエ−ト誘導体およびその塩
US4684631A (en) 1984-10-09 1987-08-04 Toyama Chemical Co., Ltd. Novel 5-fluoro-2-deoxyuridine derivatives and salts thereof, process for producing the same, and antitumor agents containing the same
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
EP0202056B1 (fr) * 1985-05-07 1989-08-30 Teijin Limited Médicament anti-tumeur
JPS6483092A (en) * 1987-09-24 1989-03-28 Arakawa Chotaro & Co Novel n6,n6-dimethyladenosine derivative having carcinostatic activity, its production and carcinostatic agent containing said derivative as active component
JP2637534B2 (ja) * 1987-10-28 1997-08-06 プロ−ニューロン,インコーポレーテッド アシルデオキシリボヌクレオシド誘導体およびその使用
JPH0278696A (ja) * 1988-09-13 1990-03-19 Shoichiro Ozaki 5−フルオロウラシル誘導体
IE980216A1 (en) 1989-04-17 2000-02-23 Scotia Holdings Plc Anti-virals
FI105556B (fi) * 1991-09-30 2000-09-15 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten pyrimidiiniukleosidijohdannaisten valmistamiseksi, joilla on kasvaimen vastaista vaikutusta

Also Published As

Publication number Publication date
DE69219482T2 (de) 1997-10-23
NO300014B1 (no) 1997-03-17
CA2120725C (fr) 2000-04-11
HU9400988D0 (en) 1994-07-28
KR100272732B1 (ko) 2000-11-15
FI990270A7 (fi) 1999-02-10
RU2126417C1 (ru) 1999-02-20
FI105035B (fi) 2000-05-31
PL170846B1 (en) 1997-01-31
CH0642525H1 (en) 1999-06-30
NZ244535A (en) 1995-08-28
GR3024149T3 (en) 1997-10-31
FI990270L (fi) 1999-02-10
NO941269L (no) 1994-04-07
UA41296C2 (uk) 2001-09-17
EP0642525A1 (fr) 1995-03-15
JPH06511249A (ja) 1994-12-15
EP0642525B1 (fr) 1997-05-02
TW347333B (en) 1998-12-11
GB2260319B (en) 1995-12-06
SG47759A1 (en) 1998-04-17
IL103351A (en) 2000-02-17
MX9205715A (es) 1993-05-01
CZ288153B6 (en) 2001-05-16
DE69219482D1 (de) 1997-06-05
GB2260319A (en) 1993-04-14
FI941574L (fi) 1994-04-06
FI941574A0 (fi) 1994-04-06
US6548486B1 (en) 2003-04-15
DK0642525T3 (da) 1997-11-03
IL103351A0 (en) 1993-03-15
CA2120725A1 (fr) 1993-04-15
GB9121257D0 (en) 1991-11-20
AU672369B2 (en) 1996-10-03
JP2873313B2 (ja) 1999-03-24
WO1993007163A1 (fr) 1993-04-15
SK39794A3 (en) 1994-10-05
HU219400B (hu) 2001-04-28
HUT68008A (en) 1995-05-29
CZ80594A3 (en) 1994-12-15
AU2867392A (en) 1993-05-03
ATE152454T1 (de) 1997-05-15
ZA927432B (en) 1993-06-09
NO941269D0 (no) 1994-04-07
FI990270A0 (fi) 1999-02-10
HK1007430A1 (en) 1999-04-09

Similar Documents

Publication Publication Date Title
SK281903B6 (sk) Monoestery, farmaceutické kompozície s ich obsahom a ich použitie
US6153594A (en) 5'-O-acylated antiviral nucleosides
HK1007430B (en) Nucleosides being o-acylated with a mono-unsaturated omega-9 c18 or c20 fatty acid
PT707481E (pt) Analogos de l-2',3'-didesoxinucleosido como agentes anti-hepatite b (hbv) e anti-hiv
JPH0656877A (ja) 抗ウイルス活性および抗ガン活性を有する2’−デオキシ−2’,2’−ジフルオロ(2,6,8−置換)−プリンヌクレオシド類およびその中間体
AU672369C (en) Chemical compounds
IE930047A1 (en) Chemical compounds
HK1003437B (en) Antiviral compounds

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20120930